Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International Inc. (PM) generates frequent news across corporate, regulatory, product and community topics, reflecting its role as an international consumer goods company focused on both cigarettes and smoke-free products. Company communications emphasize a transition toward a smoke-free future, with updates on heat-not-burn systems, nicotine pouches and e‑vapor products, as well as broader ambitions in wellness and healthcare.
News about PMI often covers its smoke-free strategy, including disclosures that smoke-free products account for a significant share of net revenues and are available in over 100 markets. Articles highlight the performance and regulatory status of brands such as IQOS heated tobacco products and ZYN nicotine pouches, including U.S. Food and Drug Administration marketing authorizations and Modified Risk Tobacco Product designations for certain products. Investors following PM can also expect coverage of major portfolio developments, such as the acquisition of Swedish Match and the integration of its oral tobacco and nicotine pouch offerings.
From a capital markets perspective, PMI news includes regular dividend declarations, earnings forecasts, and participation in investor conferences, as reported in regulatory news releases and Form 8‑K filings. The company also announces new bond issuances, credit facilities, and note redemptions, which are relevant to those tracking its balance sheet and funding strategy.
In the United States, PMI U.S. features prominently in news about manufacturing investments, job creation and community initiatives. Releases describe substantial U.S.-related investments in manufacturing capabilities, commercial rights and infrastructure, as well as philanthropic campaigns such as "Thanks for Giving" and the WeCare program, which support nonprofits across multiple regions. Motorsport sponsorships, including an expanded partnership with Scuderia Ferrari HP featuring ZYN branding at selected Formula 1 races, also appear in PMI’s news flow.
For investors, analysts and observers, the PM news page is a central place to review these developments, from smoke-free product milestones and regulatory decisions to financing transactions, organizational changes and community engagement efforts.
Philip Morris International (PM) has unveiled its Low Carbon Transition Plan (LCTP), aiming for carbon neutrality in direct operations by 2025 and across its entire value chain by 2040. This plan emphasizes supplier engagement and the adoption of science-based targets to meet the Paris Agreement goals. The company employs a three-step approach: enhancing energy efficiency, transitioning to renewable sources, and investing in nature-based solutions. PMI has received recognition for its climate actions, achieving a perfect score in the Dow Jones Sustainability Index.
Philip Morris International Inc. (NYSE: PM) revises its 2021 full-year reported diluted EPS forecast to $5.77 to $5.82, reflecting a growth of 13% to 14% when adjusted for currency. For Q3, reported diluted EPS grew by 4.7% to $1.55, with adjusted EPS up by 11.3% to $1.58. Heated tobacco unit shipments rose by 23.8%, contributing to a significant increase in smoke-free product revenues, which now represent 28.6% of total revenues. The company also raised its quarterly dividend by 4.2% and plans continued investment despite ongoing device supply challenges due to semiconductor shortages.
Philip Morris International (NYSE: PM) will hold a live audio webcast on
Philip Morris International (PM) announced on September 29, 2021, the establishment of a $2.5 billion revolving credit facility, expiring on September 29, 2026, as part of its Business Transformation-Linked Financing Framework. This facility replaces a previous $3.5 billion credit line. Pricing may adjust based on progress in business transformation metrics related to smoke-free products. The company aims to accelerate its transition away from traditional cigarettes, with over 14.7 million adults globally adopting IQOS products.
Philip Morris International (PM) released a survey revealing that misinformation about smoke-free products hinders progress towards a smoke-free future. Conducted by Povaddo across 26 countries, the survey indicates that 79% of respondents believe adult smokers should have accurate information about smoke-free alternatives. Despite this demand, nearly 50% of adults incorrectly perceive e-cigarettes as equally harmful as traditional cigarettes. The findings highlight the need for better education on smoke-free options, as 91% of smokers who switched cited accurate information as crucial in their decision.
Philip Morris International CEO Jacek Olczak spoke at the 2021 Concordia Annual Summit, emphasizing the lessons learned from COVID-19 and advocating for innovative partnerships to tackle global issues. He highlighted the challenge of transitioning from traditional tobacco products to scientifically-backed smoke-free alternatives, underscoring the resistance from certain anti-tobacco groups. Olczak noted the significant potential for harm reduction, particularly citing the decline in cigarette use in Japan due to heated tobacco products. PMI aims to transform the tobacco industry, targeting a smoke-free future.
PMI has successfully acquired 74.77% of Vectura shares, surpassing the required 50% threshold for an unconditional offer. This acquisition, part of PMI's strategy to advance its Beyond Nicotine ambitions, aims to generate at least $1 billion from new product lines by 2025. The partnership will enhance Vectura’s development in inhaled therapeutics, leveraging PMI’s substantial investments of $8.1 billion since 2008 in smoke-free innovations. With its extensive pipeline of inhaled products, Vectura is set to play a pivotal role in PMI's transformation into adjacent health sectors.
Philip Morris International (PM) has completed its acquisition of Fertin Pharma for DKK 5.1 billion (approximately USD 820 million). This strategic move aims to enhance PM's portfolio of smoke-free products and expand into self-care wellness markets. Fertin Pharma, with its 850+ employees and expertise in oral delivery systems, is expected to significantly contribute to PM's 2025 objectives of generating over 50% of revenues from smoke-free products. The acquisition's impact on PM's full-year 2021 adjusted EPS is expected to be immaterial.
The Board of Directors of Philip Morris International (NYSE: PM) has increased the quarterly dividend by 4.2% to an annualized rate of
Philip Morris International (NYSE: PM) has reaffirmed its 2021 full-year diluted EPS forecast, expecting a range between
FAQ
What is the current stock price of Philip Morris (PM)?
What is the market cap of Philip Morris (PM)?
